- Home
- ACHV vs TRUE Comparison
ACHV vs TRUE Comparison
Compare ACHV & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- TRUE
- Stock Information
- Founded
- ACHV N/A
- TRUE 2005
- Country
- ACHV United States
- TRUE United States
- Employees
- ACHV N/A
- TRUE N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TRUE Computer Software: Programming Data Processing
- Sector
- ACHV Health Care
- TRUE Technology
- Exchange
- ACHV Nasdaq
- TRUE Nasdaq
- Market Cap
- ACHV 167.6M
- TRUE 175.1M
- IPO Year
- ACHV N/A
- TRUE 2014
- Fundamental
- Price
- ACHV $4.81
- TRUE $2.19
- Analyst Decision
- ACHV Strong Buy
- TRUE Hold
- Analyst Count
- ACHV 1
- TRUE 5
- Target Price
- ACHV $12.00
- TRUE $3.28
- AVG Volume (30 Days)
- ACHV 2.4M
- TRUE 1.4M
- Earning Date
- ACHV 11-06-2025
- TRUE 11-06-2025
- Dividend Yield
- ACHV N/A
- TRUE N/A
- EPS Growth
- ACHV N/A
- TRUE N/A
- EPS
- ACHV N/A
- TRUE N/A
- Revenue
- ACHV N/A
- TRUE $184,559,000.00
- Revenue This Year
- ACHV N/A
- TRUE $9.14
- Revenue Next Year
- ACHV N/A
- TRUE $7.47
- P/E Ratio
- ACHV N/A
- TRUE N/A
- Revenue Growth
- ACHV N/A
- TRUE 11.66
- 52 Week Low
- ACHV $1.84
- TRUE $1.05
- 52 Week High
- ACHV $5.78
- TRUE $4.62
- Technical
- Relative Strength Index (RSI)
- ACHV 61.90
- TRUE 51.81
- Support Level
- ACHV $4.65
- TRUE $2.00
- Resistance Level
- ACHV $5.42
- TRUE $2.48
- Average True Range (ATR)
- ACHV 0.44
- TRUE 0.07
- MACD
- ACHV 0.02
- TRUE -0.01
- Stochastic Oscillator
- ACHV 64.34
- TRUE 39.58
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.